text:
América FC is een Braziliaanse voetbalclub uit São José do Rio Preto, in de deelstaat São Paulo.

Geschiedenis
De club werd opgericht in 1946 en werd vernoemd naar America FC uit Rio de Janeiro en nam zelfs het clublogo van deze club over. Op 17 maart 1946 speelde de club haar eerste wedstrijd en won met 3-1 van Ferroviária. In 1957 werd de club kampioen van de tweede klasse en promoveerde zo naar de hoogste klasse van het Campeonato Paulista.

Externe link
 Officiële website

Braziliaanse voetbalclub
Voetbalclub uit São Paulo (staat)

redpajama_set_name: RedPajamaWikipedia


text:
MG Contemporary Not as Grim As It Sounds
(Image from Barnes & Noble)
Louise "Lou" Montgomery loves to sing, but not in the way her mother wants her to. Convinced that Lou's going to make it big any day now, her mother drags her from place to place insisting that she perform in front of any crowd they can find. Twelve-year-old Lou can't stand the noisy groups, all the people looking at her, or the way some people want to touch her. She knows her quirks are weird, but sometimes the sensory overload makes her feel like she's going to explode. Lou and her mom need the money her gigs provide so they can find somewhere to live besides their truck, but she would do anything not to have to perform ever again.
When Lou accidentally crashes the truck and her unstable living situation becomes known, Child Protective Services steps in. Lou is sent to live with an aunt and uncle in Nashville. For the first time she realizes what she's been missing—a clean home that's not on wheels, nutritious meals, going to school, guardians who put her first, etc. When her Sensory Processing Disorder (SPD) is officially diagnosed for the first time, Lou even begins to understand the condition that has always confused and plagued her. Lou's new life is a million times better than her old one. Does she really want to be reunited with the mother who neglected and exploited her? If Lou can't save her mom, who will?
Although the plot summary of Tune It Out by Jamie Sumner makes the middle-grade novel sound pretty grim, it's actually a funny, hopeful book that's more upbeat than not. Lou is a sympathetic character, even if she's also kind of a self-centered one. It's easy to root for her as she begins to get the stability and care she deserves. Yes, she acts older than 12 and yes, her story is predictable, but overall, Tune It Out is an enjoyable novel. It brings the challenges of living with an SPD to light and teaches an important lesson about the fact that no one is "normal." Everyone has quirks and differences that should be viewed with empathy and understanding. With further lessons about family, friendship, and finding your way, Tune It Out is an appealing, compelling novel.
(Readalikes: Hm, I can't think of anything. You?)
If this were a movie, it would be rated:
for brief, mild language (no F-bombs) and tough subject matter (parental neglect, homelessness, etc.)
To the FTC, with love: Another library fine find
Labels:B Grade Books,Cybils Awards,Family Dramas,Homelessness,Jamie Sumner,Middle Grade Books,Music,PG-rated books,Sensory Processing Disorder (SPD),U.S. Settings: Tennessee | 3 bookworm(s) said...
MG Novel-in-Verse a Gut-Wrenching, Illuminating Illegal Immigration Story
Betita Quintero loves going to fourth grade in her East Los Angeles neighborhood. There, a beloved teacher has been showing her how to express her feelings using vivid "word-poems." She has plenty of emotions to illustrate—happiness from being surrounded by loving parents and a poor, but supportive community of immigrants; excitement over the impending birth of her baby sibling; and fear of her parents' undocumented status being discovered. Betita's worst nightmare comes true when her father is arrested by Immigration and Customs Enforcement (ICE) and deported to Mexico. Now, she and her pregnant mother are worried, scared, and on their own. How can they survive without Papi?
Things go from bad to worse when Betita and her mom are detained, locked away in a dirty cell with other terrified refugees. How will they survive in such a hopeless, joyless place? Will her Mami's baby be okay? Most of all, will the Quintero family ever be reunited?
Land of the Cranes by Aida Salazar (who was born in Mexico and brought to the United States by her undocumented parents when she was a baby) tells a gut-wrenching, heartrending story that is all too timely and real. It's grim and disturbing in a lot of ways, but it's also hopeful and beautifully told in verse. No matter what you think of U.S. immigration policy and its enforcement, it's impossible not to be moved by this illuminating story. It's a quick read, but a powerful one that has stuck with me for months.
(Readalikes: Reminds me of Efrèn Divided by Ernesto Cisneros)
for violence, language, and disturbing subject matter
Labels:Aida Salazar,B Grade Books,Books in Verse,Cybils Awards,Family Dramas,Illegal Immigration,Latinx Authors,Mexico/Mexican Culture,Middle Grade Books,PG-rated books,U.S. Settings: California | 3 bookworm(s) said...
MG Novel-in-Verse a Gut-Wrenching, Illuminating Il...

redpajama_set_name: RedPajamaCommonCrawl


Edify Corp., a subsidiary of S1 Corp., has announced the availability of version 6.2 of its Electronic Workforce (EWF) product.
EWF is a customer interaction platform that enables the development of applications that deliver automated customer service via voice, e-mail, fax, wireless and Web channels.
Included in among the new features in version 6.2 are dynamic grammars that make it possible to personalize speech recognitions by adding new phrases, a single phrase correction capability that increases customer ease-of-use, and support of speech recognition in 21 languages.


Do you sometimes forget a dose of your medication? Taking medications as directed can be a challenge. When you're busy, it's easy to forget a pill or two. For people who are juggling more than one prescription medication, it's even harder. You need to remember which pills you're supposed to take and at what times. You also need to remember to visit the pharmacy to pick up refills before you run out of your medications.
With so much to remember, it's no wonder you're not taking your medications as prescribed. While missing a couple doses here and there may not seem like a big deal, it can affect the effectiveness of your medications. Fortunately, there's an easy way to stay on top of your medications: a drug adherence program.
A drug adherence program reminds patients to take their medications. These programs send reminders through text messages, emails, or mobile phone apps. When you receive a notification, you'll know it's time to take your medication. This makes regulating your doses easy.
These programs can also provide refill alerts. When you're getting low on your medication, you'll get a notification to pick up refills. If you often forget about refills until you run out of a necessary medication, these notifications can be very helpful.
Some adherence programs also let you view your dose history and adherence. You can see how well you've been following your dosage instructions. With this information, you can track your progress or show your doctor how well you've been taking your medications.
It can be hard to remember to take medications every day. Some medications need to be taken at precise times, and that makes it even more challenging. With the help of a drug adherence program, you can remember to take your various medications on time. As soon as the notification goes off, you can take your medication and go on with your day.
If you have several medications to keep track of, these notifications can help you feel less stressed about tracking your doses. Notifications can make it simple for you to take a medication at the precise time, even if you have an irregular schedule or can't watch the clock.
Remembering to take your medications at the right times is a big part of keeping yourself healthy. Missing doses, or taking them at the wrong times, could have health consequences. For medications to work properly, they need to be taken as prescribed. For example, if you take medications to control epilepsy, missing a dose could cause a breakthrough seizure. Missing a dose of insulin could lead to high blood sugar levels in diabetics. These are just two examples.
To find out what the consequences of forgetting your medications could be, talk to your doctor.
Drug adherence programs can make your life easier and help you stay healthy, so signing up for them is an easy decision. If you're interested in these programs, you have many options. Health insurance companies may offer these programs to their plan members. There are also many apps available that will help you track your medications. These apps offer many different features, so shop around to find one that meets your needs. For example, if you have diabetes, you may want an app that lets you record blood sugar readings in addition to reminding you to take your insulin.
Forgetting to take medications can have health consequences. To regulate your doses and stay on track, try using a drug adherence program. With these simple programs, you'll get the reminders you need to take your medications.
Tierney is a communications specialist with over 12 years of experience in two industries, working with sales and marketing teams to develop and carry out marketing communications plans. Tierney has tackled projects including small and large scale advertising campaigns, print and digital marketing design, as well as copywriting and editing work. Off the clock, Tierney loves managing messy home renovations with her husband, muddy walks in the park with her schnauzer, and sleepless nights with her two toddlers. Her passions also include travel, photography, curling, and black and white movies.


text:
AMRI partners with Bruker, HighRes in mass spectrometry for drug discovery
by Angus Liu |
Feb 8, 2017 1:50pm
AMRI teams up with Bruker Baltonics and HighRes Biosolutions to advance mass spectrometry in drug discovery. (Times Union)
Mass spectrometry has in recent decades been widely used in drug discovery, and CRO AMRI just tapped Bruker Daltonics and HighRes Biosolutions to develop new applications for such services.
The core component of the partnership lies in AMRI's acquisition of the new MALDI PharmaPulse system from Bruker and HighRes for deployment at its Integrated Drug Discovery Center.
Under the agreement, Bruker and HighRes will help train and provide consulting to AMRI biologists in developing protocols on the system.
"The protocols we can develop by applying the latest MS technologies to assay development have enormous potential for many disease areas, including such challenging areas as Alzheimer's disease and other neurological diseases," said Grant Carr, senior director of lead discovery at AMRI, in a press release.
Germany-based Bruker is famous for its analytical instruments for application in the biopharma industry and research, and many of its products are used to study the physical structure and biological characteristics of molecules and atoms. Woburn, Massachusetts-based HighRes, on the other hand, is focused on robotic systems and laboratory devices for usage in the same industry.
The two companies first announced the breakthrough high-throughput screening (HTS) solution for drug discovery in 2015. It is based on the autoflex speed MALDI-TOF system from Bruker and an integrated robotics and automation program from HighRes. The companies at that time touted it as "the fastest commercially available mass spectrometry-based screening solution with significantly lower cost per sample."
Besides, the label-free feature of the system could accelerate assay development and potentially minimize artifacts interference from the labels used in traditional HTS technologies.
As indicated in its name, the HTS system is based on matrix-assisted laser desorption ionization (MALDI) technology and could process a sample in about one second when it first came into being. The companies just recently upgraded it to enable analysis of up to 10 different samples per second, as announced at the SLAS 2017 event in Washington, D.C.
Pharma companies have been implementing high-throughput technologies for hit identification, one of the very early stages of drug discovery, as the process usually involves screening a large amount of compounds. The new MALDI PharmaPulse systems is capable of screening more than 10,000 samples per day in hit discovery mode.
Two biopharma giants, Boehringer Ingelheim and Genentech, have completed installations of the newly upgraded system in late 2016 at their facilities in Biberach, Germany, and San Francisco, California, respectively, said Meike Hamester, director of the Pharmaceutical Business Unit at Bruker Daltonics, in a press release.
Albany, New York-based AMRI will utilize its biological understanding and expertise to further develop the MALDI PharmaPulse technology for application in complex cell-based assays and an expanded portfolio of MS-based biochemical assays.
drug discovery Drug Discovery Software AMRI Bruker Daltronics
GSK bets on tech to help boost lagging R&D
As GlaxoSmithKline looks to start a 23andMe-partnered test this year, the Big Pharma is increasingly looking to tech for its R&D.
by Ben Adams Jan 21, 2020 7:25am
LabCorp's CRO unit Covance doubles down on cell, gene therapies
LabCorp has unveiled a new suite of cell and gene therapy development offerings from Covance as it looks to get into this burgeoning area.
JPM: Execs on where the industry should look beyond cancer
Oncology is clearly a major medical and societal issue, but one that sees too much focus from biopharmas at the expense of other killers.
by Ben Adams, by Amirah Al Idrus Jan 17, 2020 10:05am
Angus Liu
https://twitter.com/rj_liu
https://www.linkedin.com/in/ruojingliu